AI
CL icon

Accredited Investors’s Colgate-Palmolive CL Stock Holding History

Accredited Investors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
4,985
+334
+7% +$29.2K 0.02% 186
2026
Q1 		$396K Sell
4,651
-7,302
-61% -$651K 0.02% 177
2025
Q4 		$945K Buy
+11,953
New +$937K 0.05% 109

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Accredited Investors's CL Position: Q2 2026 in Review

Accredited Investors increased its Colgate-Palmolive (CL) stake by 7.2% in Q2 2026, buying an estimated $29.2K and bringing the position to 4,985 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #186.

Accredited Investors first reported a position in CL in Q4 2025 and has held it in 3 quarters since. The position peaked at $945K in Q4 2025. 647 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Accredited Investors held 4,985 shares of Colgate-Palmolive worth $457K as of Q2 2026.
  • Accredited Investors bought 334 Colgate-Palmolive shares in Q2 2026, an estimated $29.2K.
  • Colgate-Palmolive made up 0.02% of Accredited Investors's portfolio in Q2 2026, its #186 holding.
  • Accredited Investors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
  • Accredited Investors's Colgate-Palmolive position peaked at $945K in Q4 2025.
  • 647 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.